Pfizer Limited Board Approves Unaudited Financial Results for Q3 FY2026
Pfizer Limited announced the unaudited financial results for the quarter and nine months ended December 31, 2025, following the Board Meeting…
Supriya Lifescience Ltd. Board Approves Q3 FY2026 Results and Key Director Appointments
Supriya Lifescience Ltd. announced the outcomes of its Board Meeting held on February 09, 2026. The board approved the Unaudited Financial…
Premier Energies Limited Board Approves Joint Venture in Renewables EPC and Extends Acquisition Deadlines
Premier Energies Limited announced key outcomes from its Board meeting on February 9, 2026. The Board approved establishing a 51% joint…
Adani Enterprises Limited Record Date Fixed for Second and Final Call on Partly Paid Shares
Adani Enterprises Limited has fixed Friday, February 13, 2026, as the Record Date for determining eligible shareholders for the Second and…
Kotak Mahindra Bank Management Transition and Appointment of New CTO
Kotak Mahindra Bank announced a significant change in its Senior Management Personnel following the resignation of Mr. Bhavnish Lathia, Chief…
Privi Speciality Chemicals Limited Board Approves Q3 FY26 Results and ₹50 Crore Equity Infusion in Subsidiary
Privi Speciality Chemicals Limited announced the outcome of its Board meeting held on February 09, 2026, approving the Unaudited Financial…
AUROBINDO PHARMA LIMITED Board Approves Q3 FY26 Results, Director Appointment, and Power Purchase Agreement
The Aurobindo Pharma Board approved the Unaudited Financial Results for Q3 FY26, ending December 31, 2025. Key actions included the…
City Union Bank RBI Approves Appointment of Shri R. Vijay Anandh as MD & CEO
The Reserve Bank of India (RBI) has conveyed its approval for the elevation of Shri R. Vijay Anandh to the position of Managing Director…
Embassy Developments Limited Strong Operational and Commercial Quarter in Q3 FY2026
Embassy Developments Limited (EDL) reported a robust Q3 FY26, achieving ₹1,392 Cr in pre-sales, marking a 240% increase QoQ. The company…
SUPRIYA LIFESCIENCE LTD. Board Approves Q3 FY26 Results and Key Director Appointments
Supriya Lifescience announced the outcome of its Board Meeting held on February 09, 2026. The Board approved the Unaudited Financial Results…